These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 21272167)

  • 21. Diphtheria-tetanus overimmunization in children with no records: can it be prevented?
    Frank JW; Schabas R; Arshinoff R; Brant R
    CMAJ; 1989 Dec; 141(12):1241-6. PubMed ID: 2590890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period.
    Miller MA; Meschievitz CK; Ballanco GA; Daum RS
    Pediatrics; 1995 Apr; 95(4):522-7. PubMed ID: 7700752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune status and immune response to diphtheria-tetanus and polio vaccines in allogeneic bone marrow-transplanted thalassemic patients.
    Li Volti S; Mauro L; Di Gregorio F; Romeo MA; Lupo L; Pizzarelli G; Mangiagli A; Giammanco G; Russo G
    Bone Marrow Transplant; 1994 Aug; 14(2):225-7. PubMed ID: 7994236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines.
    Nordøy T; Husebekk A; Aaberge IS; Jenum PA; Samdal HH; Flugsrud LB; Kristoffersen AC; Holte H; Kvaløy S; Kolstad A
    Bone Marrow Transplant; 2001 Oct; 28(7):681-7. PubMed ID: 11704791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular immunity as a potential cause of local reactions to booster vaccination with diphtheria and tetanus toxoids and acellular pertussis antigens.
    Scheifele DW; Ochnio JJ; Halperin SA
    Pediatr Infect Dis J; 2009 Nov; 28(11):985-9. PubMed ID: 19755930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine as a single-dose booster in Singaporean adults.
    Chan SH; Tan PT; Han HH; Bock HL
    Singapore Med J; 2006 Apr; 47(4):286-90. PubMed ID: 16572239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Revaccination of children after completion of standard chemotherapy for acute leukemia.
    Patel SR; Ortín M; Cohen BJ; Borrow R; Irving D; Sheldon J; Heath PT
    Clin Infect Dis; 2007 Mar; 44(5):635-42. PubMed ID: 17278052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Humoral immune response after post-chemotherapy booster diphtheria-tetanus-pertussis vaccine in pediatric oncology patients.
    Cheng FW; Leung TF; Chan PK; Lee V; Shing MK; Chik KW; Yuen PM; Li CK
    Pediatr Blood Cancer; 2009 Feb; 52(2):248-53. PubMed ID: 18937325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and immunogenicity of Haemophilus influenzae type B vaccine given in combination with DTwP at 6, 10 and 14 weeks of age.
    Cherian T; Thomas N; Raghupathy P; Durot I; Dutta A
    Indian Pediatr; 2002 May; 39(5):427-36. PubMed ID: 12037271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An open-label, randomized, multicenter study of the safety, tolerability, and immunogenicity of quadrivalent human papillomavirus (types 6/11/16/18) vaccine given concomitantly with diphtheria, tetanus, pertussis, and poliomyelitis vaccine in healthy adolescents 11 to 17 years of age.
    Vesikari T; Van Damme P; Lindblad N; Pfletschinger U; Radley D; Ryan D; Vuocolo S; Haupt RM; Guris D
    Pediatr Infect Dis J; 2010 Apr; 29(4):314-8. PubMed ID: 19952980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular and humoral responses to tetanus vaccination in Gabonese children.
    van Riet E; Retra K; Adegnika AA; Jol-van der Zijde CM; Uh HW; Lell B; Issifou S; Kremsner PG; Yazdanbakhsh M; van Tol MJ; Hartgers FC
    Vaccine; 2008 Jul; 26(29-30):3690-5. PubMed ID: 18539369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Kinetics of vaccination antibodies against tetanus toxoid, diphtheria toxoid, measles virus, poliomyelitis virus and pneumococcus after allogenic and autologous bone marrow transplantation and booster vaccination. 2: Kinetics of vaccination antibodies against diphtheria toxoid after allogenic and autologous bone marrow transplantation].
    Prager J; Thilo W; Hermann J; Fuchs D; Zintl F
    Kinderarztl Prax; 1992 Oct; 60(7):195-8. PubMed ID: 1434337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The induction and suppression of in vitro IgG anti-tetanus toxoid antibody synthesis by human lymphocytes stimulated with tetanus toxoid in the absence of in vivo booster immunizations.
    Lum LG; Culbertson NJ
    J Immunol; 1985 Jul; 135(1):185-91. PubMed ID: 2582031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunogenicity and safety of a tetanus-diphtheria vaccine (adult type): clinical trial in adults].
    Gil A; Dal-Ré R; González A; Lasheras L; Aguilar L; del Rey J
    Med Clin (Barc); 1995 Feb; 104(4):126-9. PubMed ID: 7898155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 15- through 20-month-old infants.
    Bernstein HH; Rothstein EP; Reisinger KS; Blatter MM; Arbeter AM; Fontana ME; Jacobs JM; Long SS; Rathfon H; Crayne O
    Pediatrics; 1994 Apr; 93(4):656-9. PubMed ID: 8134224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response to diphtheria and tetanus booster vaccination in pediatric renal transplant recipients.
    Enke BU; Bökenkamp A; Offner G; Bartmann P; Brodehl J
    Transplantation; 1997 Jul; 64(2):237-41. PubMed ID: 9256180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonspecific Regulation of the Number of Immunocompetent Cells Under the Influence of DT Toxoid in Children With Glomerulonephritis.
    Kostinov MP; Akhmatova NK; Magarshak OO; Vlasenko AE; Polishchuk VB; Kostinova AM; Mashilov KV
    Front Immunol; 2021; 12():715389. PubMed ID: 34691025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunity to diphtheria and tetanus in a young population on a dialysis regimen or with a renal transplant.
    Ghio L; Pedrazzi C; Assael BM; Panuccio A; Foti M; Edefonti A
    J Pediatr; 1997 Jun; 130(6):987-9. PubMed ID: 9202624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Course of immunization titers after pediatric kidney transplantation and association with glomerular filtration rate and kidney function.
    Beil S; Kreuzer M; Pape L
    Transplantation; 2012 Dec; 94(11):e69-71. PubMed ID: 23222744
    [No Abstract]   [Full Text] [Related]  

  • 40. Impaired primary immune response in type-1 diabetes: results from a controlled vaccination study.
    Eibl N; Spatz M; Fischer GF; Mayr WR; Samstag A; Wolf HM; Schernthaner G; Eibl MM
    Clin Immunol; 2002 Jun; 103(3 Pt 1):249-59. PubMed ID: 12173299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.